Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
Main Page
 Other
 MS
 Photos
 Videos
This Month
October 2007
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

Favorite Links
  • MS Watch
  • my daughters blog
  • my new blog

    Month Archive
    December 2007
    November 2007
    October 2007
    September 2007
    August 2007
    		•
    Main Page  »  Research
    « Previous  |  Next »
    Wednesday, October 31
    View Article  Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis
    by All About MS on Wed 31 Oct 2007 09:00 AM CST

    Tysabri (natalizumab) – study how Tysabri effects quality of life in multiple sclerosis


    Department of Neurology,

    Mellen Center for Multiple Sclerosis Treatment and Research,

    Cleveland ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    View Article  Stem Cell Therapies- International Distribution System
    by All About MS on Wed 31 Oct 2007 07:59 AM CST

    Vavici™ Announces Formation of First Comprehensive International Distribution System for Stem Cell Therapies

    NEW YORK--(BUSINESS WIRE)—

     

    Vavici has announced its plans to create ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    View Article  Tysabri - when stopping using there is increase disease activity
    by All About MS on Wed 31 Oct 2007 07:57 AM CST

    Disease Activity Increases After MS Patients Stop Natalizumab (Tysabri) Treatment

     

    ST. PAUL, MN -- September 12, 2007 -- People with multiple sclerosis (MS) who ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    Tuesday, October 30
    View Article  Disease Benefit with HE3286 in Model of Multiple Sclerosis
    by All About MS on Tue 30 Oct 2007 08:00 AM CST



    Disease Benefit with HE3286 in Model of Multiple Sclerosis Highlighted at 2nd International Congress on Immune-Mediated Diseases


    Hollis-Eden Pharmaceuticals Reports on Anti-Inflammatory Activity with HE3286 ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    Monday, October 29
    View Article  VITAMIN D SUPPLEMENTS
    by All About MS on Mon 29 Oct 2007 11:50 AM CST

    VITAMIN D SUPPLEMENTS APPEAR TO BE ASSOCIATED WITH LOWER RISK OF DEATH

    CHICAGO—Individuals who take vitamin D supplements appear to have a lower risk of ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    Sunday, October 28
    View Article  COPAXONE® Had Significantly Lower Risk of Relapse than Patients Using Rebif®
    by All About MS on Sun 28 Oct 2007 12:00 AM CST

    Study Showed Patients Using COPAXONE® Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif® in Relapsing-Remitting Multiple Sclerosis (RRMS)...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    Saturday, October 27
    View Article  Acne Medication May Delay Progress of Multiple Sclerosis
    by All About MS on Sat 27 Oct 2007 08:18 AM CST

    Multiple Sclerosis Society of Canada Oct 25, 2007 12:30 ET

     

    Multiple Sclerosis Society of Canada:

    Acne Medication May Delay Progress of Multiple Sclerosis

     ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos
    View Article  COPAXONE® is More Cost Effective Than Tysabri®
    by All About MS on Sat 27 Oct 2007 07:51 AM CST

    New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE® is More Cost Effective Than Tysabri® for Treatment of Relapsing-Remitting Multiple Sclerosis

    Markov Model ...   more »

    Leave Comment  |  Permanent Link  |  Cosmos